An overview of animal models in experimental schistosomiasis and refinements in the use of non-human primates

Laboratory Animals

Volumn 35, Issue 3, 2001, Pages 205-212

  Farah, Idle O ^a,b   Kariuki, Thomas M ^a,b   King, Christopher L ^c   Hau, Jann ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b INSTITUTE OF PRIMATE RESEARCH   (Kenya)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Animal models; Animal welfare; Humane endpoints; Non human primates; Refinement; Schistosoma mansoni

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; MONOCLONAL ANTIBODY; PRAZIQUANTEL; VACCINE;

ANIMAL HUSBANDRY; ANIMAL MODEL; ANIMAL WELFARE; BABOON; CHIMPANZEE; EUTHANASIA; IMMUNE RESPONSE; IMMUNIZATION; NONHUMAN; PRIMATE; RESEARCH; REVIEW; RODENT; SCHISTOSOMA; SCHISTOSOMIASIS;

ANIMAL WELFARE; ANIMALS; DISEASE MODELS, ANIMAL; ENDPOINT DETERMINATION; FEMALE; GUIDELINES; HOST-PARASITE RELATIONS; MALE; PRIMATES; SCHISTOSOMIASIS;

ANIMALIA; MAMMALIA; PAN TROGLODYTES; PAPIO HAMADRYAS; PRIMATES; RODENTIA; SCHISTOSOMA; SCHISTOSOMA MANSONI;

EID: 0034961969     PISSN: 00236772     EISSN: None     Source Type: Journal    
DOI: 10.1258/0023677011911570     Document Type: Review

References (47)

1. Hepatocellular carcinoma associated with chronic Schistosoma mansoni infection in a chimpanzee
2. Tumor necrosis factor alpha restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice
3. The use of non-human primates as laboratory animals in Europe - Moving toward the zero option
4. Schistosomiasis vaccines: Research to development
5. Enhanced Th1 and dampened Th2 responses synergize to inhibit acute granulomatous and fibrotic responses in murine Schistosomiasis mansoni
6. Schistosomiasis: Forty years' war on the worm
7. Immunoglubulin E and effector cells in schistosomiasis
8. Chemotherapy of schistosomiasis: An update
9. The radiation-attenuated vaccine against schistosomes in animal models: Paradigm for a human vaccine?
10. Elimination of a primary schistosome infection from rats coincides with elevated IgE titres and mast cell degranulation
11. The schistosome egg granuloma: Immunopathology in the cause of host protection or parasite survival?
12. Immunology of hepatosplenic schistosomiasis mansoni: A human perspective
13. The isolation of a 22 kDa band after SDS-PAGE of Schistosoma mansoni adult worms and its use to demonstrate that IgE responses against the antigen(s) it contains are associated with human resistance to reinfection
14. Immunopathology of schistosomia-sis: A cautionary tale of mice and man
15. Repeated exposure induces periportal fibrosis in Schistosoma mansoni-infected baboons: Role of TGF-beta and IL-4
16. Schistosoma mansoni induces in the Kenyan baboon a novel intestinal pathology that is manifestly modulated by an irradiated cercarial vaccine
17. Schistosoma mansoni: Development and modulation of the granuloma after or multiple exposures in the baboon (Papio cynocephalus anubis)
18. Baboons as reserviour hosts of Schistosoma mansoni
19. Puberty and age-related changes in susceptibility to schistosome infection
20. Egg deposition is the major stimulus for the production of Th2 cytokines in murine Schistosoma mansoni
21. Humane endpoints and the importance of training
22. Regulation of T helper cell differentiation by STAT molecules
23. Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response
24. Increased interleukin-4 and interleukin-5 production in response to Schistosoma haematobium adult worm antigens correlates with lack of reinfection after treatment
25. Cytokine control of the granulomatous response in Schistosoma mansoni-infected baboons: Role of exposure and treatment
26. Schistosoma mansoni infection in a natural population of Olive baboons (Papio cynocephalus anubis) in Gombe Stream National Park
27. The baboon as a non-human primate model of human schistosome infection
28. Role of adult worm antigen-specific immunoglobulin E in acquired immunity to Schistosoma mansoni infection in baboons
29. Evasion of the immune response by parasites
30. Schistosoma mansoni in IL-4-deficient mice
31. Schistosoma mansoni in the baboon: The natural history of chronic infections after single and multiple exposures
32. Protective immunity in baboons vaccinated with a recombinant antigen or radiation attenuated cercariae is antibody dependent
33. Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni
34. Schistosoma mansoni in the baboon (Papio anubis): Parasitological responses of Kenyan baboons to different exposures of a local parasite strain
35. Observations on the ability of repeated, light exposures to Schistosoma mansoni cercariae to induce resistance to reinfection in Kenyan baboons (Papio anubis)
36. Health monitoring of non-human primate colonies
37. Functional properties of a rat monoclonal IgE antibody specific for Schistosoma mansoni
38. Leaky livers, portal shunting and immunity to schistosomes
39. Why don't we have a schistosomiasis vaccine?
40. Cytokine regulation of granuloma formation in schistosomiasis
41. An IL- 12 based vaccination method for preventing fibrosis induced by schistosome infections
42. Analysis of cytokine mRNA expression during primary granuloma formation induced by the eggs of S. Mansoni
43. Protective immunity to Schistosoma mansoni induced in the olive baboon, Papio anubis, by irradiated cercariae vaccine